Real-time enrollment status for this hematopoietic and lymphatic system neoplasm clinical trial
Current Status
Recruiting
Checked: July 14, 2026 at 1:25 AM UTC
| NCT Number | NCT07332312 |
| Recruiting Status | Recruiting |
| Condition | Hematopoietic and Lymphatic System Neoplasm |
| Phase | Clinical Trial |
| Target Enrollment | 71 participants |
| Active Locations | 2 sites in the US |
| Sponsor | University of Southern California |
| Last Updated on CT.gov | May 11, 2026 (May 11, 2026) |
As of July 14, 2026: Clinical trial NCT07332312 is currently recruiting participants. This clinical trial study for hematopoietic and lymphatic system neoplasm is actively seeking new participants at 2 locations across the United States. The study is sponsored by University of Southern California. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07332312 is actively recruiting participants as of July 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07332312 was last updated May 11, 2026 (May 11, 2026). HelloStudys verifies this status automatically.